One of these patients, ACC-2, whose tumor harbored the somatic frameshift mutation with loss of the wild-type allele of BRCA2, received cisplatinum after a recurrence, with liver metastasis and experienced complete remission of the recurring tumor (Supplementary Figure S4). Here, BRCA2 is linked to neoplasm.